Trial Profile
A Phase 1, Single Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Tolerability of Ascending Dose Levels of Single Intrathecal Injections of AYX1 versus Intrathecal Injections of Placebo in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Sep 2015
Price :
$35
*
At a glance
- Drugs Brivoligide (Primary)
- Indications Postoperative pain
- Focus Adverse reactions
- 06 Sep 2012 New trial record
- 05 Sep 2012 Results were reported in a Adynxx media release.